These tumours express ER to a lesser extent [9, 10], have a poorer prognosis, and share molecular features similar to those of triple-negative breast cancer and serous ovarian cancer, including a high frequency of p53 mutations and copy number alterations [11]. The gene discussed is ESR1; the disease is neoplasm.